ZD6474 in Treating Patients With Small Cell Lung Cancer
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: ZD6474 may stop the growth of tumor cells by blocking some of the enzymes needed
for cell growth. ZD6474 may also stop the growth of small cell lung cancer by blocking blood
flow to the tumor.
PURPOSE: This randomized phase II trial is studying how well ZD6474 works compared to placebo
in treating patients with small cell lung cancer that has responded to previous chemotherapy
with or without radiation therapy.